Last reviewed · How we verify

NCT05510856

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Completed Phase 4 Last updated 22 November 2024
What this trial tests

Phase 4 trial testing Duloxetine in Oncology in 93 participants. Completed in 15 October 2024.

Timeline
1 September 2022
Primary endpoint
30 September 2024
15 October 2024

Quick facts

Lead sponsorTanta University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment93
Start date1 September 2022
Primary completion30 September 2024
Estimated completion15 October 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

18 and older, any sex, with Oncology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the possible efficacy of duloxetine, gabapentin and lacosamide on oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs.
    Kee JX, Yau JNN, Kumar Muthuramalingam RP, Wang X, et al · · 2025 · cited 6× · PMID 40985211 · DOI 10.1021/acs.chemrev.5c00041
  2. Oxaliplatin-induced peripheral neuropathy: from pathogenesis to treatment.
    Zhou HY, Deng Q, Gao SQ, Zhou JT, et al · · 2026 · PMID 41811525 · DOI 10.1007/s00520-026-10549-6
  3. Comparative study evaluating the efficacy of duloxetine, gabapentin, and lacosamide on oxaliplatin-induced peripheral neuropathy.
    Tantawy SS, Ibrahim OM, El-Haggar SM, Shehata MA. · · 2025 · PMID 41255847 · DOI 10.1097/pr9.0000000000001366

Verify or expand the search:

Other trials of Duloxetine

Trials testing the same drug.

Other recruiting trials for Oncology

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05510856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing